Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Consejo Superior De Investigaciones Cientificas is currently managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are distributed across 2 distinct art units, indicating that the organization's biological research is being reviewed by different specialized groups. The involvement of distinct examiners means that each case is being handled by a different individual, which may lead to different prosecution timelines.
RAGHU, GANAPATHIRAM is the busiest examiner for the portfolio, currently overseeing 1 pending office action. Since he only handles 1 of the pending office actions, the organization's risk is split between the examiners. This lack of concentration means that the organization must maintain separate prosecution strategies for its Biotechnology & Pharmaceuticals filings. Practitioners should be aware that the art units and examiners may have different interpretations of the prior art. Success in a case does not necessarily guarantee a similar result in the other, given the different individuals involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.5% |
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18854359 | ENZYMES AND METHOD FOR BIODEGRADING POLYOLEFIN-DERIVED POLYMERS | RAGHU, GANAPATHIRAM | — |
| 18843911 | COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF | KIM, SEONG JONG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18854359 | ENZYMES AND METHOD FOR BIODEGRADING POLYOLEFIN-DERIVED POLYMERS | RAGHU, GANAPATHIRAM | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18854359 | ENZYMES AND METHOD FOR BIODEGRADING POLYOLEFIN-DERIVED POLYMERS | RAGHU, GANAPATHIRAM | 1652 | §101§103§112DP | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18843911 | COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF | KIM, SEONG JONG | 1621 | §103§112 | Non-Final OA | — | Pending | Sep 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialConsejo Superior De Investigaciones Cientificas has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Ganapathiram Raghu has the most, with 1 of Consejo Superior De Investigaciones Cientificas's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
